In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.
about
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosisEhrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatmentClinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting.Emergence of the ehrlichioses as human health problems.In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, anDNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp.Use of aminoglycosides in treatment of infections due to intracellular bacteriaTicks and tickborne bacterial diseases in humans: an emerging infectious threat.Traditional and molecular techniques for the study of emerging bacterial diseases: one laboratory's perspective.Ehrlichia chaffeensis: a prototypical emerging pathogen.Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States.Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum.Treatment of tick-borne diseases.Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycinsCytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines.Successful Treatment of Human Monocytic Ehrlichiosis with RifampinRevisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosisDiagnosis and treatment of tick infestation and tick-borne diseases with cutaneous manifestations.Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR.Seroepidemiology of rickettsial infections in Morocco.Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR.Human monocytic ehrlichiosis presenting as acute appendicitis during pregnancy.Tetracyclines in pediatrics revisited.
P2860
Q24658293-6C698E0B-90A4-4520-9DD4-899950BF73E6Q28307155-BB549D70-DE09-4EED-A9B6-645D7A037239Q33349873-93354B68-59D4-4C41-9141-0D0720061FF0Q33497606-B45D8348-7E3C-4D3E-BF46-0C9A6EA3217EQ33979566-F9D2FA2C-0B35-48DB-A7F3-624A49B3759EQ33982545-94D9A853-8E59-4AD6-AE4B-B159962E67D2Q33983252-AA1F0A9F-7624-49B2-A64D-0EADB4F13FCCQ34180273-0F56E4FD-9816-413D-8E7D-84CE2544ACD4Q34565309-90DB6DA8-3976-4DB2-B1BC-D7052C012CE8Q34580035-F4010411-E5C5-45B2-9C6F-D67D6F4826F0Q34725597-ECB0AF71-C785-4217-A57E-7D4DAEA9EC98Q34750777-0120F35D-FA25-4D25-AF79-FBB3311575D8Q34874402-B7454677-7915-4400-B389-224F09A610E4Q35131023-B1E5470A-EBE8-44E6-95B2-F125FE59053AQ35772578-D1AD7241-07F9-4036-9418-CAA937B79369Q36552264-F56926CF-CD8B-4958-B2B9-6E1F48DBB7ACQ36981470-6087926E-FFE7-43B8-A04B-C2EF526EEE40Q37355914-4E576BE7-0632-4556-A07D-8F811F335091Q37542337-1A397B5A-92F9-4DFF-A26B-20EC5DBDA317Q37625411-D657D53B-A654-4901-9E0B-41078306D667Q39247075-48A372CB-0ACC-47FF-9FEB-2249B5C6CCA6Q39746369-490760C1-A39D-4AAC-B88D-CB1863944A9BQ51700753-5F66F02A-F841-487D-97BA-02DC8AB29773Q53969308-0D566F89-751A-493D-95C4-2BAF9E3893DF
P2860
In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@ast
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@en
type
label
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@ast
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@en
prefLabel
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@ast
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@en
P2860
P356
P1476
In vitro antibiotic susceptibi ...... humans, Ehrlichia chaffeensis.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.12.2799
P407
P577
1992-12-01T00:00:00Z